Results 91 to 100 of about 377,839 (219)

Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?

Journal of Infection and Public Health, 2012
Summary: A structured questionnaire was administered to health-care workers (HCWs). The HCWs were also screened for measles, rubella, mumps, and varicella (MMRV) using serological methods. One thousand two hundred and fifty-five HCWs were tested.
Emine Alp, Fatma Cevahir, Selma Gökahmetoglu, Hayati Demiraslan, Mehmet Doganay   +4 more
doaj   +1 more source

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine. [PDF]

Int Med Case Rep J, 2023
Achdiat PA, Yunitasari, Usman HA, Maharani RH.   +3 more
europepmc   +1 more source

Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand. [PDF]

Clin Exp Vaccine Res, 2023
Sirithammaphan U, Chaisang U, Pongrattanamarn K.   +2 more
europepmc   +1 more source

Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital

Australian and New Zealand Journal of Public Health, 2016
Objective: To determine seroprotection for the vaccine‐preventable diseases (VPDs) measles, mumps, rubella, varicella and hepatitis B among new employees seen at a Victorian tertiary hospital staff clinic.
Eden C. Andrew, Katherine B. Gibney, Justin Denholm, Karin Leder   +3 more
doaj   +1 more source

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children

The Turkish Journal of Pediatrics, 2000
A total of 44 children aged between 15-18 months were randomly vaccinated either with a new measles-mumps-rubella (MMR) vaccine (Priorix, SmithKline Beecham) or a commercially available MMR vaccine (MMR-II, Merck) to compare the reactogenicity and
G Kanra, M Ceyhan, E Ozmert
doaj  

Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts? [PDF]

Oman Med J, 2022
Al-Mendalawi MD.
europepmc   +1 more source

Efficacy of Intralesional Measles Mumps Rubella Vaccine in the Treatment of Verruca Vulgaris: An Interventional Study. [PDF]

Cureus, 2023
Surani AS, Un R, Marfatia Y.
europepmc   +1 more source

Advisory Committee on Immunization Practices (ACIP) : Measles, Mumps, and Rubella (MMR) Vaccine Work Group [PDF]

01-MMR-Temte ...

core   +4 more sources

Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy

Vaccines
Background: Despite the efforts of the World Health Organization, some childhood viral diseases, for which there is already an effective vaccine, have not yet been eradicated. Among these, we find varicella, mumps, measles, and rubella, which although in
Brunella Perfetto, Giovanna Paduano, Elena Grimaldi, Vincenza Sansone, Giovanna Donnarumma, Gabriella Di Giuseppe   +5 more
doaj   +1 more source

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. [PDF]

MMWR Morb Mortal Wkly Rep, 2022
Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K.   +5 more
europepmc   +1 more source